Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery

Completed · Phase 4 · Has a placebo group

Conditions studied: Pain

In brief

All pediatric patients who undergo cardiac surgery require analgesic medications for postoperative pain control and many require sedation to facilitate comfort with cares. Parasternal infiltration of local anesthetic for nerve blocks is a simple option to postoperative analgesia. The investigators hypothesize that Bupivacaine, a parasternal nerve block administered in pediatric patients undergoing cardiac surgery will reduce the requirement of Opioids and other pain medications as well as decrease postoperative pain scores. This is a prospective, double-blind, randomized controlled trial. Subjects are randomized to receive either 0.25% Bupivacaine or normal saline following their cardiothoracic surgery.

Key facts

Study ID

NCT02512861

Run by

Children's Hospitals and Clinics of Minnesota

People needed

93

Starts

2014-04-01

Expected to finish

2015-11-01

Last updated by the study team

2018-08-22

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 0-17 years old at time of surgery
• Society of Thoracic Surgeons- European Association for Cardio-Thoracic Surgery (STAT) mortality categories 1-3
• Surgical intervention requiring median sternotomy
• Expected extubation within 24 hours of surgery

You may not qualify if…

• Known allergic reaction or hypersensitivity to Bupivacaine or to any local anesthetic agent of the amide type
• Delayed sternum closure

Where it is running

• Children's Hospitals and Clinics of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.